REG - Indivior PLC - Director Declaration

IndiviorAnnouncement

16/11/2018 15:55

RNS Number : 6702H
Indivior PLC
16 November 2018
 


Indivior PLC - Director Declaration
 
Indivior PLC confirms that Daniel Tassé, Senior Independent Director, will be appointed Chief Executive Officer of DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq: DBVT), a clinical stage biopharmaceutical company, with effect from November 29, 2018.
 
There have been no other changes to the information set out in LR 9.6.13R (2) to LR 9.6.13R (6) in respect of Mr Tassé.
 
This announcement is made in accordance with Listing Rule 9.6.14.
 
Kathryn Hudson
Company Secretary




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNFKADQPBDDFDD